Companies that lost sales

While diagnostics and imaging companies seemingly benefited the most from the COVID-19 pandemic, other elective procedure device companies took revenue hits.

Teleflex
–2.2% lower sales.
5.1% growth in R&D spending.
–2.8% fewer employees.

Intuitive Surgical
–2.7% lower sales.
6.8% growth in R&D spending.
10.3% growth in employees.

Stryker
–3.6% lower sales.
1.3% growth in R&D spending.
7.5% growth in employees.

Abbott (medical device segment)
–3.7% lower sales.
8.3% growth in R&D spending.

Boston Scientific
–7.7% lower sales.
–2.6% lower R&D spending.
5.6% growth in employees.

Owens & Minor
–7.9% lower sales.

GE Healthcare
–9.7% lower sales.

Alcon
–9.9% lower sales.
2.6% growth in R&D spending.
18.3% growth in employees.

Smith+Nephew
–11.2% lower sales.
5.1% growth in R&D spending.
2.9% growth in employees.

Johnson & Johnson (medical device segment)
–11.6% lower sales.
7.2% growth in R&D.

Zimmer Biomet
–12% lower sales.
–17.2% lower R&D spending.
0.5% growth in employees.

Dentsply Sirona
–17.1% lower sales.
–12.4% lower R&D spending.
–1.3% fewer employees.

The top 7 medtech CEO quotes on COVID-19, one year later>>